UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Oxford review of economic policy, ISSN 0266-903X, 01/2020, Volume 36, pp. S14 - S37
Journal Article
The Quarterly journal of economics, ISSN 0033-5533, 11/2016, Volume 131, Issue 4, pp. 1593 - 1636
Journal Article
The Economists' voice, ISSN 2194-6167, 05/2020, Volume 17, Issue 1
Journal Article
4.
Full Text
What is the meaning of (statistical) life? Benefit-cost analysis in the time of COVID-19
Oxford review of economic policy, ISSN 0266-903X, 01/2020, Volume 36, pp. S56 - S63
Journal Article
5.
Full Text
Homburg’s Lockdown Analysis: Conclusions without Data and an Appropriate Estimation Model
The Economists' voice, ISSN 2194-6167, 08/2020, Volume 17, Issue 1
Journal Article
Applied economic perspectives and policy, ISSN 2040-5790, 03/2021, Volume 43, Issue 1, pp. 105 - 119
Journal Article
Environmental & resource economics, ISSN 0924-6460, 8/2011, Volume 49, Issue 4, pp. 539 - 559
Economic Policy | I18 | Discrete choice modeling | Economics/Management Science, general | Environmental Economics | Survey questions | M31 | Q51 | Economics / Management Science | Environmental Law/Policy/Ecojustice | Environmental Management | Contingent valuation | Economics | Environmental Studies | Social Sciences | Life Sciences & Biomedicine | Business & Economics | Environmental Sciences & Ecology | Science & Technology | Contingent valuation; Discrete choice modeling; Survey questions; Q51; D6; H4; I18; M31 | Valuation | Analysis | Studies | Data collection | Statistical methods | Preferences | Surveys | Collection | Nomenclatures | Clarity
Journal Article
Applied economic perspectives and policy, ISSN 2040-5790, 12/2020, Volume 42, Issue 4, pp. 674 - 694
Journal Article
The European journal of health economics, ISSN 1618-7598, 1/2018, Volume 19, Issue 1, pp. 123 - 152
Health Economics | Public Health | Public Finance | Political Economy/Economic Policy | Value assessment | Systematic review | Health Care Management | Expert consultation | I11 (Analysis of Health Care Markets) | Health technology assessment (HTA) | High cost medicines | I10 (General) | I18 (Government Policy | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | Pharmaceutical policy | European Union | Innovative medicines | I (Health, Education, and Welfare) | Regulation | I1 (Health) | Economics | Social Sciences | Life Sciences & Biomedicine | Business & Economics | Health Care Sciences & Services | Health Policy & Services | Science & Technology | Drug Costs | Drug Discovery | Europe | Technology Assessment, Biomedical | Drugs | Public health | Studies | Drug therapy | Decision making | Index Medicus | Original Paper | I18 (Government Policy; Regulation; Public Health)
Journal Article
The Quarterly journal of economics, ISSN 0033-5533, 8/2012, Volume 127, Issue 3, pp. 1057 - 1106
Health insurance | Health outcomes | Hospital admissions | P values | Lotteries | Insurance coverage | Credit insurance | Mental health insurance | Medicaid | Self reports | Economics | Business & Economics | Social Sciences | User statistics | Low income groups | Studies | Health services utilization | Uninsured people
Journal Article
Journal of population economics, ISSN 0933-1433, 2020, Volume 34, Issue 1, pp. 275 - 301
COVID-19 | Lockdown | Coronavirus | Machine learning | Economics | Business & Economics | Social Sciences | Demography | Dynamic structural analysis | Evaluation | Contagion | Delayed | Unpredictable | Time series | Health risks | Viral diseases | Viruses | Infections | Coronaviruses | Early warnings | Policy analysis | Learning | Learning algorithms | Detection
Journal Article
Journal of health economics, ISSN 0167-6296, 05/2016, Volume 47, pp. 20 - 33
Innovation | Technical success rates | Discount rate | Pharmaceutical industry | R&D cost | Economics | Social Sciences | Life Sciences & Biomedicine | Health Care Sciences & Services | Business & Economics | Health Policy & Services | Science & Technology | Costs and Cost Analysis | Biomedical Research - economics | Capital Financing | United States | Drug Industry | Innovations | Costs | Drug industry | Personal expenditure | Research & development--R&D | Companies | Drug development | Marketing | Studies | Inflation | Cost estimates | Research & development expenditures | Out of pocket costs | Inflation rates | Taxation | Approval | Pharmaceuticals | Health administration | Drugs | Estimates
Journal Article
Public administration review, ISSN 0033-3352, 07/2020, Volume 80, Issue 4, pp. 651 - 656
Journal Article